ACE2 and COVID-19: The dysregulation of ACE2 has been found to be associated with fluctuations in COVID-19 morbidity and the serine-protease TMPRSS2 has been found to be needed in the priming of the virus in preparation to its entry into the host cell (Hoffmann et al., 2020).